Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial

被引:22
|
作者
Beishuizen, Cathrien R. L. [1 ]
Coley, Nicola [2 ]
van Charante, Eric P. Moll [3 ]
van Gool, Willem A. [1 ]
Richard, Edo [1 ,4 ]
Andrieu, Sandrine [2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands
[2] Univ Paul Sabatier, Inst Natl Sante & Rech Med, Ctr Hosp Univ Toulouse, Dept Epidemiol & Publ Hlth,UMR1027,Univ Toulouse, Toulouse, France
[3] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Dept Neurol, Donders Ctr Brain Cognit & Behav, Nijmegen, Netherlands
关键词
dementia prevention; dropout; nonadherence; aged; randomized controlled trial; CARDIAC REHABILITATION; ALZHEIMERS-DISEASE; OLDER-PEOPLE; RISK-FACTORS; ATTRITION; PREDICTORS; INTERVENTION; ADHERENCE; PROGRAM; APATHY;
D O I
10.1111/jgs.14834
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To explore and compare sociodemographic, clinical, and neuropsychiatric determinants of dropout and nonadherence in older people participating in an open-label cluster-randomized controlled trial-the Prevention of Dementia by Intensive Vascular care (preDIVA) trial-over 6 years. DESIGN: Secondary analysis. SETTING: One hundred sixteen general practices in the Netherlands. PARTICIPANTS: Community-dwelling individuals aged 70 to 78 (N = 2,994). INTERVENTION: Nurse-led multidomain intervention targeting cardiovascular risk factors to prevent dementia. MEASUREMENTS: The associations between participant baseline sociodemographic (age, sex, education), clinical (medical history, disability, cardiovascular risk), neuropsychiatric (depressive symptoms (Geriatric Depression Scale-15), and cognitive (Mini-Mental State Examination)) characteristics and dropout from the trial and nonadherence to the trial intervention were explored using multi-level logistic regression models. RESULTS: Older age, poorer cognitive function, more symptoms of depression, and greater disability were the most important determinants of dropout of older people. The presence of cardiovascular risk factors was not associated with dropout but was associated with nonadherence. Being overweight was a risk factor for nonadherence, whereas people with high blood pressure or a low level of physical exercise adhered better to the intervention. The association between poorer cognitive function and symptoms of depression and dropout was stronger in the control group than in the intervention group, and vice versa for increased disability. CONCLUSION: In a large dementia prevention trial with 6-year follow-up, dropout was associated with older age, poorer cognitive function, symptoms of depression, and disability at baseline. These findings can help to guide the design of future dementia prevention trials in older adults. The associations found between cardiovascular risk factors and nonadherence need to be confirmed in other older populations receiving cardiovascular prevention interventions.
引用
收藏
页码:1505 / 1513
页数:9
相关论文
共 50 条
  • [31] A randomized controlled trial of fall prevention strategies in old peoples' homes
    McMurdo, MET
    Millar, AM
    Daly, F
    GERONTOLOGY, 2000, 46 (02) : 83 - 87
  • [32] Efficacy of a Parent-Based, Indicated Prevention for Anorexia Nervosa: Randomized Controlled Trial
    Jacobi, Corinna
    Huetter, Kristian
    Voelker, Ulrike
    Moebius, Katharina
    Richter, Robert
    Trockel, Mickey
    Bell, Megan Jones
    Lock, James
    Taylor, C. Barr
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2018, 20 (12)
  • [33] The feasibility of a sleep education program for informal dementia care dyads: A pilot randomized controlled trial
    Song, Yeonsu
    Papazyan, Anna
    Lee, Diane
    Mitchell, Michael N.
    McCurry, Susan M.
    Irwin, Michael R.
    Teng, Edmond
    Alessi, Cathy A.
    Martin, Jennifer L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (04) : 1207 - 1215
  • [34] Dementia prevention, intervention, and care
    Livingston, Gill
    Sommerlad, Andrew
    Orgeta, Vasiliki
    Costafreda, Sergi G.
    Huntley, Jonathan
    Ames, David
    Ballard, Clive
    Banerjee, Sube
    Burns, Alistair
    Cohen-Mansfield, Jiska
    Cooper, Claudia
    Fox, Nick
    Gitlin, Laura N.
    Howard, Robert
    Kales, Helen C.
    Larson, Eric B.
    Ritchie, Karen
    Rockwood, Kenneth
    Sampson, Elizabeth L.
    Samus, Quincy
    Schneider, Lon S.
    Selbaek, Geir
    Teri, Linda
    Mukadam, Naaheed
    LANCET, 2017, 390 (10113) : 2673 - 2734
  • [35] A stepped care relapse prevention program for depression in older people: a randomized controlled trial
    Apil, Sachlan R. A.
    Hoencamp, Erik
    Haffmans, P. M. Judith
    Spinhoven, Philip
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (06) : 583 - 591
  • [36] Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
    van den Elsen, Geke A. H.
    Ahmed, Amir I. A.
    Verkes, Robbert-Jan
    Kramers, Cees
    Feuth, Ton
    Rosenberg, Paul B.
    van der Marck, Marjolein A.
    Rikkert, Marcel G. M. Olde
    NEUROLOGY, 2015, 84 (23) : 2338 - 2346
  • [37] Exergaming as a Physical Exercise Strategy Reduces Frailty in People With Dementia: A Randomized Controlled Trial
    Karssemeijer, Esther G. A.
    Bossers, Willem J. R.
    Aaronson, Justine A.
    Sanders, Lianne M. J.
    Kessels, Roy P. C.
    Rikkert, Marcel G. M. Olde
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (12) : 1502 - +
  • [38] Multimodal dementia prevention - does trial design mask efficacy?
    Scarmeas, Nikolaos
    NATURE REVIEWS NEUROLOGY, 2017, 13 (06) : 323 - 324
  • [39] Treatment of vascular dementia: The route of prevention
    Sorrentino, G.
    Migliaccio, R.
    Bonavita, V.
    EUROPEAN NEUROLOGY, 2008, 60 (05) : 217 - 223
  • [40] Falls and Physical Activity in Persons With Mild to Moderate Dementia Participating in an Intensive Motor Training Randomized Controlled Trial
    Zieschang, Tania
    Schwenk, Michael
    Becker, Clemens
    Uhlmann, Lorenz
    Oster, Peter
    Hauer, Klaus
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2017, 31 (04) : 307 - 314